EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Atypical pneumonia testing in transplant recipients

Fionna Feller iD, Paul Trubin, Maricar Malinis iD, Joshua S Vogel, Jacob Merwede, David R Peaper, Marwan M Azar iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Fionna Feller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Transplant Recipients, Immunocompromised Host. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The incidence of atypical pneumonia among immunocompromised patients is not well characterized. Establishing a diagnosis of atypical pneumonia is challenging as positive tests must be carefully interpreted. We aimed to assess the test positivity rate and incidence of atypical pneumonia in transplant recipients.

Methods

A retrospective cohort study was conducted at the Yale New Haven Health System in Connecticut. Adults with solid organ transplant, hematopoietic stem cell transplant (HSCT), or chimeric antigen receptor T‐cell, who underwent testing for atypical pathogens of pneumonia ( Legionella pneumophilia , Mycoplasma pneumoniae , Chlamydia pneumoniae , and Bordetella pertussis) between January 2016 and August 2022 were included. Positive results were adjudicated in a clinical context using pre‐defined criteria. A cost analysis of diagnostic testing was performed.

Results

Note that, 1021 unique tests for atypical pathogens of pneumonia were performed among 481 transplant recipients. The testing positivity rate was 0.7% ( n = 7). After clinical adjudication, there were three cases of proven Legionella and one case of possible Mycoplasma infection. All cases of legionellosis were in transplant recipients within 1‐year post‐transplantation with recently augmented immunosuppression and lymphopenia. The possible case of Mycoplasma infection was in an HSCT recipient with augmented immunosuppression. The cost of all tests ordered was $50,797.73.

Conclusion

The positivity rate of tests for atypical pneumonia was very low in this transplant cohort. An algorithmic approach that targets testing for those with compatible host, clinical, radiographic, and epidemiologic factors, and provides guidance on test selection and test interpretation, may improve the diagnostic yield and lead to substantial cost savings. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplant RecipientsImmunocompromised HostHumansRetrospective StudiesMaleMiddle AgedFemaleAdultHematopoietic Stem Cell TransplantationAgedOrgan TransplantationIncidenceMycoplasma pneumoniaeBordetella pertussisChlamydophila pneumoniaeConnecticut

Stichwörter der Autor:innen

atypicalbone marrow transplantimmunocompromisedpneumoniasolid organ transplanttransplant

Autor:innen und Institutionen

  • Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Section of Infectious Diseases, Veteran Affairs Tennessee Valley Healthcare, Nashville, Tennessee, USA.
  • Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Microbiology, Yale New Haven Hospital, New Haven, Connecticut, USA.
  • Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Fionna Feller, Maricar Malinis, Marwan M Azar

Zitieren

APA

Feller, F., Trubin, P., Malinis, M., Vogel, J. S., Merwede, J., Peaper, D. R., & Azar, M. M. (2024). Atypical pneumonia testing in transplant recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14256

Vancouver

Feller F, Trubin P, Malinis M, Vogel JS, Merwede J, Peaper DR, et al. Atypical pneumonia testing in transplant recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14256

BibTeX
@article{Feller2024,
  author = {Feller, Fionna and Trubin, Paul and Malinis, Maricar and Vogel, Joshua S and Merwede, Jacob and Peaper, David R and Azar, Marwan M},
  title = {Atypical pneumonia testing in transplant recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14256}
}
Kostenlos starten →